KURE KraneShares MSCI All China Hlth Care ETF
MSCI China All Shares HC 10/40 NR USD

NAV as of 02-Dec-2022

20.5200

4 Week: 19.04 - 21.04

52 Week: 16.79 - 34.44

Latest Closing Price

20.83

Premium / Discount

1.76

Expense Ratio

0.65%

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, track the price and yield performance of the MSCI China All Shares Health Care 10/40 Index. The fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in instruments in its underlying index or in instruments that have economic characteristics similar to those in the underlying index. The underlying index is a free float adjusted market capitalization weighted index, subject to the 10/40 Constraint, which is designed to measure the equity market performance of Chinese companies in the healthcare sector. The fund is non-diversified.

Main Fund Characteristics

Fund Manager:
KraneShares
Asset Under Management:
96,485,304
Launch Date:
30/01/2018
Asset Class:
Equity
Replication Method:
Physical-Sample
Number of Holdings:
87
Trading Currency:
USD
Style:
Large Growth
Region/Sector/Strategy:
China / N.A / N.A
Exchange:
NYSE

Performance

Period Performance Returns(%) Volatility(%) Risk Adjusted Performance
YTD-27.422.38-11.51
1 Day-0.810.000.00
1 Week6.675.271.26
1 Month4.2510.000.43
3 Months4.1521.610.19
6 Months3.6526.120.14
1 Year-37.8240.37-0.94
2 Years-40.0653.40-0.75
3 Years-7.0865.64-0.11
5 Years0.000.000.00
10 Years0.000.000.00

Price History

-

Annual Performance Return

2012201320142015201620172018201920202021
Price (%) 0.00000.00000.00000.00000.00000.00000.000034.031467.2826-15.8569
Nav (%) 0.00000.00000.00000.00000.00000.00000.00000.00000.00000.0000
Rank 0.00000.00000.00000.00000.00000.00000.000029.00009.000070.0000

Dividend Frequency

Lastest Dividend

Ex Date Payment Date Dividend Payout per unit
N.A

Portfolio Data

Total Number of Holdings: 87

Number of Bond Holdings: 0

Number of Equity Holdings: 84

Total Market Value: 96,485,304

Portfolio Composition

Top 10 Holdings

% Portfolio Weight Shares Owned Shares Changed Market Value
1WuXi Biologics (Cayman) Inc8.23911,165,135014,662,923

Country Exposure

Regional Exposure

America

Greater Europe

Greater Asia

Market Classification

Market Capitalization

Size% of portfolio
Giant40.46
Large48.32
Medium9.87
Small1.20
Micro0.00

Equity Style Box Breakdown

000Large
000Mid
000Small
ValueBlendGrowth

Value Measures

Price/Prospective Earnings*

20.4349

Price/Book*

3.3024

Price/Sales*

2.0967

Price/Cash Flow*

16.5352

Dividend Yield*

1.2560

Growth Measures

Long-Term Earnings

17.6335

Historical Earnings

24.0643

Sales Growth

15.3148

Cash-Flow Growth

23.2120

Book-Value Growth

17.4059

*Forward-looking based on historical data.

Equity Sector

Number of Bond Holdings

0

Bond Statitics

DetailValue
Average Effective Duration0
Average Effective Maturity (Years)*0
Average Credit Quality0
Average Weighted Coupon*0
Average Weighted Price*0

Bond Style Box Breakdown

000HighQuality
000Med
000Low
LtdModExt
Interest-Rate Sensitivity

Credit Quality

Type% Bonds
N.A

Bond Sector

Type
% Bonds

Bond Maturity

% Bonds
N.A

Data Source: Morningstar

© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:

(1) include the proprietary information of Morningstar and Morningstar’s third party licensors;
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.

Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.